Caricamento...
It is time to consider third-line options in antiretroviral-experienced paediatric patients?
BACKGROUND: The historic use of full-dose ritonavir as part of an unboosted protease inhibitor (PI)-based antiretroviral therapy regimen in some South African children contributes to the frequent accumulation of major PI resistance mutations. METHODS: In order to describe the prevalence of major PI...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The International AIDS Society
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228719/ https://ncbi.nlm.nih.gov/pubmed/22085598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-2652-14-55 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|